Search research articles
Contact Us
Filters
Showing results (61-70 of 62) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 62 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Phase I and pharmacologic study of the tyrosine kinase inhibitor SU101 in patients with advanced solid tumors
S G Eckhardt, J Rizzo, K R Sweeney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2000
Phase I and pharmacokinetic study of irofulven, a novel mushroom-derived cytotoxin, administered for five consecutive days every four weeks in patients with advanced solid malignancies
S G Eckhardt, S D Baker, C D Britten, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 62) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 62 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Phase I and pharmacologic study of the tyrosine kinase inhibitor SU101 in patients with advanced solid tumors
S G Eckhardt, J Rizzo, K R Sweeney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2000
Phase I and pharmacokinetic study of irofulven, a novel mushroom-derived cytotoxin, administered for five consecutive days every four weeks in patients with advanced solid malignancies
S G Eckhardt, S D Baker, C D Britten, et al.
Page
of 7